-
1
Journal Article
by DE OLIVEIRA, Gildàsio S ALMEIDA, Marcela D BENZON, Honorio T MCCARTHY, Robert J Published in Anesthesiology (Philadelphia) (2011)“...Dexamethasone is frequently administered in the perioperative period to reduce postoperative nausea and vomiting. In contrast, the analgesic effects of...”
-
2
Journal Article
-
3
Journal Article
-
4
Journal Article
by Nagashima, Hitoshi Kushiro, Masayo Nakagawa, Hiroyuki Published in Environmental toxicology and pharmacology (01.01.2011)“...Tricothecene mycotoxins, such as nivalenol, are toxic to leukocytes. To elucidate the molecular mechanism of nivalenol toxicity, we investigated the...”
-
5
Journal Article
by Wang, Qin Jiang, Jiayu Chen, Wenfei Jiang, Hao Zhang, Zhirong Sun, Xun Published in Journal of controlled release (28.05.2016)“...Glucocorticoid (GC) is the cornerstone therapy of rheumatoid arthritis, but high doses are associated with serious adverse effects. In an effort to improve the...”
-
6
Journal Article
by Pan, Qing Xu, Qingguo Boylan, Nicholas J Lamb, Nicholas W Emmert, David G Yang, Jeh-Chang Tang, Li Heflin, Tom Alwadani, Saeed Eberhart, Charles G Stark, Walter J Hanes, Justin Published in Journal of controlled release (10.03.2015)“...Immunologic graft rejection is one of the main causes of short and long-term graft failure in corneal transplantation. Steroids are the most commonly used...”
-
7
Journal Article
by Kantarjian, Hagop Thomas, Deborah O'Brien, Susan Cortes, Jorge Giles, Francis Jeha, Sima Bueso‐Ramos, Carlos E Pierce, Sherry Shan, Jianqin Koller, Charles Beran, Miloslav Keating, Michael Freireich, Emil J Published in Cancer (15.12.2004)“...BACKGROUND Modern intensive chemotherapy regimens have improved the prognosis for patients with adult acute lymphocytic leukemia (ALL). With these regimens,...”
-
8
Journal Article
by Giovanni Palladini Angela Dispenzieri Morie A. Gertz Shaji Kumar Ashutosh Wechalekar Philip N. Hawkins Stefan Schönland Ute Hegenbart Raymond Comenzo Efstathios Kastritis Meletios A. Dimopoulos Arnaud Jaccard Catherine Klersy Giampaolo Merlini Published in Journal of clinical oncology (20.12.2012)“...To identify the criteria for hematologic and cardiac response to treatment in immunoglobulin light chain (AL) amyloidosis based on survival analysis of a large...”
-
9
Journal Article
by ROSINOL, Laura ORIOL, Albert ETXEBESTE, Ma Asuncion DIAZ-MEDIAVILLA, Joaquin HERNANDEZ, Miguel T DE ARRIBA, Felipe GUTIERREZ, Norma C MARTIN-RAMOS, Ma Luisa CIBEIRA, Ma. Teresa MATEOS, Ma. Victoria MARTINEZ, Joaqufn ALEGRE, Adrian ISABEL TERUEL, Ana LAHUERTA, Juan José SAN MIGUEL, Jesus BLADE, Joan HERNANDEZ, Dolores LOPEZ-JIMENEZ, Javier DE LA RUBIA, Javier GRANELL, Miquel BESALDUCH, Joan PALOMERA, Luis GONZALEZ, Yolanda Published in Blood (2012)“...The Spanish Myeloma Group conducted a trial to compare bortezomib/thalidomide/dexamethasone (VTD) versus thalidomide/dexamethasone (TD) versus vincristine,...”
-
10
Journal Article
by El Kechai, Naila Mamelle, Elisabeth Nguyen, Yann Huang, Nicolas Nicolas, Valérie Chaminade, Pierre Yen-Nicolaÿ, Stéphanie Gueutin, Claire Granger, Benjamin Ferrary, Evelyne Agnely, Florence Bochot, Amélie Published in Journal of controlled release (28.03.2016)“...The inner ear is one of the most challenging organs for drug delivery, mainly because of the blood-perilymph barrier. Therefore, local rather than systemic...”
-
11
Journal Article
by Palumbo, Antonio Chanan-Khan, Asher Weisel, Katja Nooka, Ajay K Masszi, Tamas Beksac, Meral Spicka, Ivan Hungria, Vania Munder, Markus Mateos, Maria V Mark, Tomer M Qi, Ming Schecter, Jordan Amin, Himal Qin, Xiang Deraedt, William Ahmadi, Tahamtan Spencer, Andrew Sonneveld, Pieter Published in The New England journal of medicine (25.08.2016)“...In a study involving patients with refractory multiple myeloma, the anti-CD38 antibody daratumumab in combination with bortezomib and dexamethasone resulted in...”
-
12
-
13
Journal Article
by Chessa, Luciana Leuzzi, Vincenzo Plebani, Alessandro Soresina, Annarosa Micheli, Roberto D'Agnano, Daniela Venturi, Tullia Molinaro, Anna Fazzi, Elisa Marini, Mirella Ferremi Leali, Pierino Quinti, Isabella Cavaliere, Filomena Monica Girelli, Gabriella Pietrogrande, Maria Cristina Finocchi, Andrea Tabolli, Stefano Abeni, Damiano Magnani, Mauro Published in Orphanet journal of rare diseases (09.01.2014)“...Ataxia Teleangiectasia [AT] is a rare neurodegenerative disease characterized by early onset ataxia, oculocutaneous teleangiectasias, immunodeficiency,...”
-
14
Journal Article
by Stewart, A. Keith Rajkumar, S. Vincent Dimopoulos, Meletios A Masszi, Tamás Špička, Ivan Oriol, Albert Hájek, Roman Rosiñol, Laura Siegel, David S Mihaylov, Georgi G Goranova-Marinova, Vesselina Rajnics, Péter Suvorov, Aleksandr Niesvizky, Ruben Jakubowiak, Andrzej J San-Miguel, Jesus F Ludwig, Heinz Wang, Michael Maisnar, Vladimír Minarik, Jiri Bensinger, William I Mateos, Maria-Victoria Ben-Yehuda, Dina Kukreti, Vishal Zojwalla, Naseem Tonda, Margaret E Yang, Xinqun Xing, Biao Moreau, Philippe Palumbo, Antonio Published in The New England journal of medicine (08.01.2015)“...In this study, the addition of carfilzomib to lenalidomide and dexamethasone improved response rates and overall survival among patients with relapsed multiple...”
-
15
Journal Article
by Dimopoulos, Meletios A, Prof Moreau, Philippe, Prof Palumbo, Antonio, Prof Joshua, Douglas, Prof Pour, Ludek, Prof Hájek, Roman, Prof Facon, Thierry, Prof Ludwig, Heinz, Prof Oriol, Albert, Prof Goldschmidt, Hartmut, Prof Rosiñol, Laura, Prof Straub, Jan, Prof Suvorov, Aleksandr, Prof Araujo, Carla, Prof Rimashevskaya, Elena, Prof Pika, Tomas, Prof Gaidano, Gianluca, Prof Weisel, Katja, Prof Goranova-Marinova, Vesselina, Prof Schwarer, Anthony, Prof Minuk, Leonard, Prof Masszi, Tamás, Prof Karamanesht, Ievgenii, Prof Offidani, Massimo, Prof Hungria, Vania, Prof Spencer, Andrew, Prof Orlowski, Robert Z, MD Gillenwater, Heidi H, MD Mohamed, Nehal, PhD Feng, Shibao, PhD Chng, Wee-Joo, Prof Published in The lancet oncology (2016)“...Summary Background Bortezomib with dexamethasone is a standard treatment option for relapsed or refractory multiple myeloma. Carfilzomib with dexamethasone has...”
-
16
Journal Article
by Dimopoulos, Meletios A Oriol, Albert Nahi, Hareth San-Miguel, Jesus Bahlis, Nizar J Usmani, Saad Z Rabin, Neil Orlowski, Robert Z Komarnicki, Mieczyslaw Suzuki, Kenshi Plesner, Torben Yoon, Sung-Soo Ben Yehuda, Dina Richardson, Paul G Goldschmidt, Hartmut Reece, Donna Lisby, Steen Khokhar, Nushmia Z O’Rourke, Lisa Chiu, Christopher Qin, Xiang Guckert, Mary Ahmadi, Tahamtan Moreau, Philippe Published in The New England journal of medicine (06.10.2016)“...The addition of daratumumab to lenalidomide and dexamethasone resulted in superior response rate and progression-free survival, as compared with lenalidomide...”
-
17
-
18
Journal Article
by Jia, Zhenshan Wang, Xiaobei Wei, Xin Zhao, Gang Foster, Kirk W Qiu, Fang Gao, Yangyang Yuan, Fang Yu, Fang Thiele, Geoffrey M Bronich, Tatiana K O’Dell, James R Wang, Dong Published in ACS nano (28.08.2018)“...Nephritis is one of the major complications of systemic lupus erythematosus. While glucocorticoids (GCs) are frequently used as the first-line treatment for...”
-
19
Journal Article
by Amjadian, Sara Seyedjafari, Ehsan Zeynali, Bahman Shabani, Iman Published in International journal of pharmaceutics (30.06.2016)“...[Display omitted] Recently, electrospun nanofibrous scaffolds are vastly taken into consideration in the bone tissue engineering due to mimicking the natural...”
-
20
Journal Article
by Griffin, Patrick T Ho, Viet Q Fulp, William Nishihori, Taiga Shain, Kenneth H Alsina, Melissa Baz, Rachid C Published in Cancer (15.10.2015)“...BACKGROUND Despite the impact of proteasome inhibitors and immunomodulatory agents, infusional chemotherapy regimens continue to be used for patients with...”
Are you a member of Bonn University? Yes: Then connect to the University network via VPN client in order to access the licensed contents. No: You can then access licensed contents using the Service Pcs within the ULB Bonn. Bitte buchen Sie den Arbeitsplatz 'Service-PC o. Scanner'
Lesen Sie bitte unsere aktuellen Informationen zur ULB im geschützten Betrieb.
